Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Sanders

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Arthritis and Rheumatism|October 1, 1991
T lymphocyte adhesion to human synovial fibroblasts. Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18R F Krzesicki, W E Fleming, G E Winterrowd, et al.
The Journal of Rheumatology|December 1, 1986
Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopyM E Sanders, J A Kopicky, F M Wigley, et al.
Arthritis and Rheumatism|October 1, 1993
Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritisP A van der Lubbe, C Reiter, F C Breedveld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma productionM E Sanders, M W Makgoba, S O Sharrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1985
Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9K A Joiner, M A Schmetz, M E Sanders, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseasesM E Sanders, E L Alexander, C L Koski, et al.
Clinical and Experimental Rheumatology|July 1, 1992
Cytarabine therapy for rheumatoid arthritisG E Bayliss, J L Juozevicius, R R Springgate, et al.
The Journal of Clinical Investigation|November 1, 1987
Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathiesC L Koski, M E Sanders, P T Swoveland, et al.
European Journal of Immunology|April 1, 1988
Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicityM W Makgoba, M E Sanders, G E Ginther Luce, et al.
The Journal of Experimental Medicine|October 1, 1987
Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoproteinB P Wallner, A Z Frey, R Tizard, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Arthritis and Rheumatism|October 1, 1991
T lymphocyte adhesion to human synovial fibroblasts. Role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18R F Krzesicki, W E Fleming, G E Winterrowd, et al.
The Journal of Rheumatology|December 1, 1986
Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopyM E Sanders, J A Kopicky, F M Wigley, et al.
Arthritis and Rheumatism|October 1, 1993
Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritisP A van der Lubbe, C Reiter, F C Breedveld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma productionM E Sanders, M W Makgoba, S O Sharrow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1985
Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9K A Joiner, M A Schmetz, M E Sanders, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseasesM E Sanders, E L Alexander, C L Koski, et al.
Clinical and Experimental Rheumatology|July 1, 1992
Cytarabine therapy for rheumatoid arthritisG E Bayliss, J L Juozevicius, R R Springgate, et al.
The Journal of Clinical Investigation|November 1, 1987
Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathiesC L Koski, M E Sanders, P T Swoveland, et al.
European Journal of Immunology|April 1, 1988
Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicityM W Makgoba, M E Sanders, G E Ginther Luce, et al.
The Journal of Experimental Medicine|October 1, 1987
Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoproteinB P Wallner, A Z Frey, R Tizard, et al.
Pageof 9